Aberrant activation of ALK has been described in a range of human cancers, including anaplastic large cell lymphoma, non-small cell lung cancer, neuroblastoma, inflammatory myofibroblastic tumors, colorectal cancer, and so on 28. The gene discussed is ALK; the disease is inflammatory myofibroblastic tumor.